The X-linked lymphoproliferative syndrome: molecular and cellular basis of the disease - Appendix 6 BIBLIOGRAPHY

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

The X-linked lymphoproliferative syndrome: molecular and cellular basis of the

disease

drs Morra, M.

Publication date

2004

Link to publication

Citation for published version (APA):

drs Morra, M. (2004). The X-linked lymphoproliferative syndrome: molecular and cellular basis

of the disease.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.

Bibliography y

AppendixAppendix 6

BIBLIOGRAPHY Y Originall Articles

1)) Funaro A, Horenstein AL, Calosso L, Morra M, Tarocco RP, Franco L, De Floraa A, Malavasi F. Identification and characterization of an active soluble form of humann CD38 in normal and pathological fluids. International Immunology. 1996; 8:: 1643-50.

2)) Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM, and Malavasi F. Rolee of human CD38 molecule in B cell activation and proliferation. Tissue Antigens.Antigens. 1997;49:7-15.

3)) Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzanii U, Stockinger Ff, Malavasi F. Human CD38 (ADP-ribosyl cyclase) is a counter-receptorr of CD31, an Ig superfamily member. Journal of Immunology.

1998;; 1:395-402.

4)) Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionallyy dependent on the TCR/CD3 complex in human T cells. FASEB JournalJournal 1998;7:581-92.

5)) Reinis M, Morra M, Funaro A, Di Primio R, Malavasi F. Functional associationss of CD38 with CD3 on the T-cell membrane. Journal of Biological RegulatorsRegulators and Homeostatic Agents. 1997; 4: 137-42.

6)) Mallone R, Ferrua S, Morra M, Zocchi E, Mehta K, Notarangelo LD, Malavasii F. Characterization of a CD38-like 78-kilodalton soluble protein released fromm B cell lines derived from patients with X-linked agammaglobulinemia. Journal ofof Clinical Investigation. 1998; 12: 2821-30.

7)11 Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangeloo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C.. The X-linked lymphoproliferative-disease gene product SAP regulates signals inducedd through the co-receptor SLAM. Nature 1998; 395: 462-9.

8)) Poy F, Yaffe MB, Sayos J, Saxena K, Morra M, Sumegi J, Cantley LC, Terhorstt C, Eck MJ. Crystal structures of the XLP protein SAP reveal a class of SH2 domainss with extended, phosphotyrosine-independent sequence recognition. MolecularMolecular Cell 1999; 4: 555-61.

9)) Sayos J, Martin M, Chen A, Simarro Grande M, Howie D, Morra M, Engel P,, Terhorst C. The cell surface receptors Ly-9 and CD84 recruit the XLP gene productt SAP. Blood. 2001. 97: 3867-74.

10)) Wang N, Morra M, Wu C, Howie D, Gullo C, Coyle T, Engel P, Terhorst C. CDD 150 is a member of a family of genes that encode glycoproteins on the surface of hematopoieticc cells. Immunogenetics. 2001. 53: 382-94.

11)) Morra M, Silander O, Calpe-Flores S, Oettgen H, Myers S, Etzioni A, Buckleyy R, Terhorst C. Alterations of the X-linked lymphoproliferative gene SH2D1AA in Common Variable Immunodeficiency patients. Blood. 2001. 98: 1321-5. 12)) Morra M, Simarro M, Martin M, Chen AS, Lanyi A, Silander O, Calpe S, Daviss J, Pawson T, Eck M, Sumegi J, Engel P, Li SC, Terhorst C. Characterization

11

See "Immunology: Sinking surveillance's flagship", News & Views, Nature 1998, 395, 441-4

AppendixAppendix 6

off SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.. Journal of Biological Chemistry. 2001. 276: 56809-18.

13)22 Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D,

Rietdijkk S, Thompson A, Coyle AJ, Denny C, Yaffe MB, Engel P, Eek MJ, Terhorst C.. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptorss in immunocytes. EMBO Journal. 2001. 20 (21): 1-13.

14)) Hwang PM, Li C, Morra M, Lillywhite J, Gertler F, Terhorst C, Kay LE, Pawsonn T, Forman-Kay J, Li SC. A "three-pronged" binding mechanism for the SAP/SH2D1AA SH2 domain - structural basis and relevance to the XLP syndrome. . EMBOEMBO Journal. 2002. 21(3): 314-323.

15)) Fraser CC, Howie D, Morra M, Qiu Y, Murphy C, Shen Q, Gutierrez-Ramos JC,, Coyle A, Kingsbury GA, Terhorst C. Identification and characterization of SF20000 and SF2001, two new members of the immune receptor SLAM/CD2 family. ImmunogeneticsImmunogenetics 2002; 53(10-11): 843-50.

16)) Parolini O, Kagerbauer B, Simonitsch-Klupp I, Ambros P, Jaeger U, Mann G, Haass OA, Morra M, Gadner H, Terhorst C, Knapp W, Holter W. Analysis of SH2D1AA mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma,, and Hodgkin's lymphoma. Annals of Hematology. 2002; 81: 441-447. 17)) Church JA, Morra M, Calpe S, Terhorst C, Cowan L, Li L. Prenatal diagnosis andd early treatment of X-linked lymphoproliferative disease. Submitted for publication publication

18)) Morra M et al. Signaling pathways involving the adapter SAP are essential for both T helperr and B cell responses. Submitted for publication

Reviewss and Chapters

1)) Morra M, Deaglio S, Calosso L, Gagliardi M, Malavasi F. Anticorpi

monoclonali.. In: Badellino F,. Zonta A, editors. Radioimmunodiagnostica e tumori dell colon-retto. Padova: Piccin. 1995.

2)2) Malavasi F, Deaglio S, Morra M, DiRosa G, Tibaldi E, Mallone R, Calosso L,, Zanotto A, Saturni L. Monoclonal Antibodies. Minerva Biotecnologica. 1996; 2: 55-7. .

3)) Morra M, Deaglio S, Mallone R, Di Rosa G, Tibaldi E, Zini G, Cinti C, Reiniss M, Malavasi F. CD38 Cluster Report. In: Kishimoto T, et al, editors. Human

Leukocytee Differentation Antigens. Oxford, U.K: Pergamon Press; 1996.

4)4) Howie D, Sayos J, Terhorst C, Morra M. The gene defective in X-linked lymphoproliferativee disease controls T cell dependent immune surveillance against Epstein-Barrr virus. Current Opinion Immunology. 2000; 4: 474-8.

5)) Morra M, Howie D, Simarro Grande M, Sayos J, Wang N, Wu C, Engel P, Terhorstt C. X-linked lymphoproliferative disease, a progressive immunodeficiency. AnnualAnnual Review of Immunology. 2001; 19: 457-72.

6)6) Sumegi J, Seemayer TA, Huang D, Davis JR, Morra M, Gross TG, Yinn L, Romeoo G, Klein E, Terhorst C, Lanyi A. A spectrum of mutations in SH2D1A that causess X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.. Leukemia & Lymphoma. 2002; 43(6): 1189-201.

22

Highlighted at Science's STKE (EAT-2 functions like SAP, 2001: 408tw)